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Neutrophil migration is essential for inflammatory responses to
kill pathogens; however, excessive neutrophilic inflammation also
leads to tissue injury and adverse effects. To discover novel thera-
peutic targets that modulate neutrophil migration, we performed
a neutrophil-specific microRNA (miRNA) overexpression screen in
zebrafish and identified 8 miRNAs as potent suppressors of
neutrophil migration. Among those,miR-199 decreases neutrophil
chemotaxis in zebrafish and human neutrophil-like cells. Intrigu-
ingly, in terminally differentiated neutrophils, miR-199 alters the
cell cycle-related pathways and directly suppresses cyclin-dependent
kinase 2 (Cdk2), whose known activity is restricted to cell cycle pro-
gression and cell differentiation. Inhibiting Cdk2, but not DNA repli-
cation, disrupts cell polarity and chemotaxis of zebrafish neutrophils
without inducing cell death. Human neutrophil-like cells deficient in
CDK2 fail to polarize and display altered signaling downstream of
the formyl peptide receptor. Chemotaxis of primary human neutro-
phils is also reduced upon CDK2 inhibition. Furthermore, miR-199
overexpression or CDK2 inhibition significantly improves the out-
come of lethal systemic inflammation challenges in zebrafish. Our
results therefore reveal previously unknown functions of miR-199
and CDK2 in regulating neutrophil migration and provide directions
in alleviating systemic inflammation.
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Neutrophils are the first cells recruited to an immune stimulusstemming from infection or sterile injuries via a mixture of
chemoattractant cues (1). In addition to eliminating pathogens,
neutrophils coordinate inflammation by activating and producing
inflammatory signals in the tissue and, in some cases, cause ad-
verse tissue damage. Overamplified or chronic neutrophil re-
cruitment directly leads to autoimmune diseases rheumatic
arthritis, diabetes, neurodegenerative diseases, and cancer (2).
Dampening neutrophil recruitment is thus a strategy to intervene
in neutrophil-orchestrated chronic inflammation (3). Despite
intensive research over the past several decades, clinical studies
targeting neutrophil migration have been largely unsuccessful,
possibly due to the prominent redundancy of adhesion receptors
and chemokines (4, 5). Additional challenges also lie in the
balance of dampening detrimental inflammation while pre-
serving immunity (6). Furthermore, neutrophil migration is
governed by spatially and temporally complex dynamic signaling
networks (7), adding yet another layer of complexity in studying
them. Immune cells use both mesenchymal migration (adhesive
migration on substrates) and amoeboid migration (actin pro-
trusion driven with weak substrate interaction) to infiltrate tissue
using distinct signaling molecules (8, 9). Thus, extensive research
is required to understand the machinery regulating neutrophil
recruitment and the interactions between signals and chemo-
tactic cues, which will lead to the development of exogenous
inhibitors for clinical use.
MicroRNAs (miRNAs) are short (20 to 22 nucleotides), con-
served, noncoding RNAs that are epigenetic regulators of the
transcriptome. By binding primarily to the 3′ untranslated regions
(3′UTRs) of their target transcripts and recruiting the RNA-
induced silencing complex, miRNAs down-regulate gene expres-
sion (10). miRNAs are generally fine-tuners that suppress gene
expression at modest levels, and also master regulators that target
the expression of a network of genes (11). Recently, miRNAs and
anti-miRNAs are used in clinical trials to treat cancer and infection
(12). In addition, they are used as screening tools to identify the
underlying mechanisms of diseases and cell behavior (13, 14). In
immune cells, an overexpression screen of miRNA was performed
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to identify miRNAs that regulate B cell tolerance (15). In neu-
trophils, the functions of the highly expressed miRNAs miR-223
(16) and miR-142 (17) have been well characterized. However,
other miRNAs and their targets as regulators of neutrophil re-
cruitment remain largely unknown. The absence of this knowledge
potentially leads to missed opportunities in harnessing miRNAs
and their targets in restraining neutrophilic inflammation.
The zebrafish is a suitable model organism to study neutrophil
biology. It has an evolutionarily conserved innate immune sys-
tem, including phagocytes and their signaling molecules, in-
cluding miRNAs (17, 18). The transparent property of zebrafish
embryos enables noninvasive imaging of neutrophil behavior
under physiological conditions (19, 20). Additionally, high fe-
cundity and established genetic tools make the zebrafish an ideal
platform for genetic screens and drug discovery (21).
We have previously established a system to express individual
miRNAs in zebrafish neutrophils to assess their function in vivo
(22). Here, we performed a miRNA overexpression screen and
identified miR-199 as a regulator of neutrophil chemotaxis.
Through miR-199 target analysis, we identified the canonical cell
cycle-related cyclin-dependent kinase 2 (cdk2) gene as a previously
unrecognized regulator of neutrophil migration. Overexpression of
miR-199 or inhibition of Cdk2 in neutrophils improved survival
upon infection and sterile inflammatory challenges. Our results
were further validated in human neutrophil-like cells and primary
human neutrophils, supporting the evolutionary conservation of
miR-199 and Cdk2 in vertebrae neutrophil biology. These dis-
coveries expand our current understanding of neutrophil mi-
gration and suggest a novel strategy to manage neutrophilic
inflammation.
Results
Identification and Characterization of miRNAs That Regulate Neutrophil
Recruitment. As a first step to understand miRNA-mediated gene
regulation in zebrafish neutrophils, we sequenced miRNAs in
zebrafish neutrophils sorted from 3-d-old embryos. Consistent with
previous reports in humans and mice, miR-223 and miR-142 were
among the miRNAs highly expressed in zebrafish neutrophils (Fig.
1 A and B and Dataset S1). As a control, we sequenced miRNAs in
the immotile epical keratinocytes and indeed detected a distinct
profile (Fig. 1 C and D). We next performed a functional genetic
screen to identify a set of miRNAs that, when overexpressed,
moderate neutrophil migration (SI Appendix, Fig. S1). Forty-one
miRNAs with lower expression levels compared with the whole
embryo or keratinocytes were selected. Individual miRNA candi-
dates were cloned and transiently expressed specifically in zebrafish
neutrophils, together with a fluorescent reporter gene. The miRNAs
whose overexpression resulted in a >50% reduction in neu-
trophil recruitment to infection sites were selected (Dataset S2) for
further validation. We generated transgenic zebrafish lines stably
expressing each of the 8 miRNAs that passed the initial screen. To
rule out potential artifacts associated with the transgene integration
sites, more than 2 independent founders were obtained for each
line. In 7 of the 8 lines, we found a significant decrease in neu-
trophil recruitment to ear infection sites, regardless of the choice of
the founder (Fig. 1E). Similarly, neutrophil recruitment was also
Fig. 1. Identification of miRNAs that suppress neutrophil recruitment in vivo. (A) DEGs of miRNAs in zebrafish neutrophils compared with whole embryo.
(B) Quantification of selected miRs that were differentially expressed in neutrophils. (C) DEGs of miRNAs in zebrafish epical keratinocytes compared with
whole embryo. (D) Quantification of selected miRs that were differentially expressed in keratinocytes. The assay was done with 3 biological repeats, each
containing cells sorted from at least 100 larvae per repeat. The result is presented as mean ± SD, using the Holm–Sidak test. (E) Neutrophil recruitment to the
infected ear in transgenic lines with neutrophil-specific overexpression of individual miRNAs. Results were normalized to the number of neutrophils recruited
in the vector-expressing control lines in each individual experiment (set as a factor of 1). (F) Neutrophil recruitment to tailfin transection sites in transgenic
lines as described in C. Representative images (G) and quantification (H) of neutrophils recruited to the infected ear in the vector ormiR-199-3–overexpressing
zebrafish line are shown. (Scale bar, 100 μm.) Representative images (I) and quantification (J) of neutrophils recruited to tailfin transection sites in the vector
or miR-199-3–overexpressing zebrafish line are shown. (Scale bar, 200 μm.) In G–J, the assays were done with at least 2 individual founders with 3 biological
repeats, each containing 25 fish per group. The result is presented as mean ± SD, using the Kruskal–Wallis test.
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significantly reduced in all 8 lines in a tailfin amputation in-
flammation model (Fig. 1F and Dataset S3), demonstrating that the
miRNA phenotypic screen was successful in identifying miRNAs
that could modulate neutrophil migration. A miRNA characterized
in our previous work, miR-722, served as a positive control (22).
Among the 8 newly identified miRNAs, miR-146 is a known sup-
pressor of immune cell activation (23), whereas the other 7 miRNAs
have not been characterized for their roles in neutrophil migration.
The overexpression of miR-199-3 resulted in the most robust in-
hibition in both models (Fig. 1 E–J), and therefore was chosen for
further characterization.
miR-199-3 Overexpression Inhibits Neutrophil Motility and Chemotaxis.
To characterize the zebrafish lines Tg(lyzC: miR-199-3-dendra2)pu19
and Tg(lyzC:vector-dendra2)pu7, henceforth referred to as the miR-
199 and vector lines, we first isolated neutrophils from these lines
and performed miRNA qRT-PCR to confirm the miR-199 over-
expression in the miR-199 line (Fig. 2A). The levels of 2 abundant
neutrophil miRNAs, miR-223 and let-7e, were not affected, dem-
onstrating that the overexpression did not disrupt physiological
miRNA levels. Total neutrophil numbers in embryos were com-
parable between the 2 lines, suggesting that the observed decreased
neutrophil recruitment was not an artifact of a reduced number of
neutrophils (Fig. 2 B and C). In addition to the defective recruit-
ment to inflammatory sites, the velocity of neutrophil spontaneous
motility in the head mesenchyme was significantly decreased in the
miR-199 line (Fig. 2 D and E and Movie S1), whereas neutrophil
directionality was not affected (Fig. 2F). The sequences of the
mature zebrafish and human miR-199-5p isoforms are identical
(Fig. 3D). We therefore sought to determine whether MIR-199
inhibits human neutrophil migration. We used MIR-100, whose
overexpression did not result in any phenotype in the initial screen,
as a negative control. We expressed humanMIR-199a,MIR-100, or
the vector alone under the control of a Tet-responsive element in
HL-60 cells, a myeloid leukemia cell line that can be differentiated
into neutrophil-like cells, as our model (24, 25) (SI Appendix, Fig.
S2A). MIR-100 and MIR-199 were individually induced in the re-
spective lines without affecting cell differentiation; cell death; or the
expression of 2 other miRNAs, MIR-223 and LET-7 (Fig. 2G and
SI Appendix, Fig. S2 B–D). The differentiated HL-60 (dHL-60) cells
were then allowed to migrate toward N-formylmethionyl-leucyl-
phenylalanine (fMLP) in transwells. Only the cells overexpressing
MIR-199, but not the vector control or cells overexpressing MIR-
100, displayed significant defects in chemotaxis (Fig. 2H). Together,
our results show that overexpression ofMIR-199 inhibits neutrophil
migration in both zebrafish and human cell models.
miR-199 Suppresses the Expression of Cell Cycle-Related Genes,
Including cdk2. To understand the underlying molecular mecha-
nism of how miR-199 regulates neutrophil migration, neutrophils
from the miR-199 or vector lines were isolated and their tran-
scripts subjected to RNA sequencing (RNAseq). Since miRNAs
generally suppress the expression of target transcripts (26), we
focused on the 512 genes significantly repressed by miR-199. The
top 10 pathways associated with the down-regulated transcripts
were related to cell cycle processes (Fig. 3 A and B and Datasets
S4 and S5). This result was surprising because neutrophils are
terminally differentiated, nonproliferative, and have exited the
cell cycle (27). To validate the RNAseq results, we selected
5 genes (cdk2, cdk5, cdca8, kif14, andmcm5) and confirmed their
Fig. 2. miR-199-3–overexpression reduces neutrophil migration in zebrafish and humans. (A) Quantification of miR-199, miR-223, and let-7e levels in
neutrophils sorted from the vector ormiR-199-3 zebrafish lines. Neutrophils were isolated from 2 adult kidney marrows from 2 different founders. Results are
normalized to u6 expression levels and presented as mean ± SD, using the Holm–Sidak test. Representative images (B) and quantification (C) of total
neutrophils in the vector or miR-199-3 zebrafish lines are shown. (Scale bar, 500 μm.) The assays were done with 3 individual founders with 3 biological
repeats, each containing 20 fish per group. The result from one representative experiment is shown as mean ± SD, using the Mann–Whitney test. Repre-
sentative images (D), velocity (E), and meandering index (F) of neutrophil motility in vector ormiR-199-3 zebrafish lines are shown. (Scale bar, 100 μm.) Three
embryos each from 3 different founders were imaged, and quantification of neutrophils in one representative video is shown. The Kruskal–Wallis test was
used. (G) Quantification of MIR-100/199, MIR-233, and LET-7E in dHL-60 cell lines with/without induced expression of the vector control or MIR-100/199. The
results from 3 independent experiments are normalized to U6 expression levels and presented as mean ± SD, using the Holm–Sidak test. DOX, doxycycline.
(H) Transwell migration of dHL-60 cells with/without induced expression of the vector control, MIR-199, or MIR-100 toward fMLP. Results are presented as
mean ± SD from 3 independent experiments and normalized to the vector −DOX + fMLP, using the Kruskal–Wallis test.
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reduced transcript levels in the miR-199–overexpressing neu-
trophils using qRT-PCR (Fig. 3C). The zebrafish ortholog of
IKBKB (inhibitor of nuclear factor kappa B kinase subunit beta),
a known target of humanMIR-199 (28) and a critical component
in the nuclear factor κB (NF-κB) pathway, was also down-
regulated, supporting the conservation of miRNA-targeted in-
teractions in zebrafish. The level of cdk1 messenger RNA
(mRNA) was not altered. Among the down-regulated cell cycle
genes, the 3′UTRs of both human and zebrafish cdk2 contain
predicted binding sites for miR-199-5p, while the protein se-
quence of CDK2 is more than 90% identical between the
2 species, showing a high degree of conservation (Fig. 3D). In
addition, among the 69 down-regulated genes in the top
10 pathways (Fig. 3B), 36 (52.1%) have interactions with cdk2,
presenting a significant enrichment (P = 2.87 × 10−32) over the
background of 4.1% (326 cdk2-interacting genes of 7,927 genes
expressed in zebrafish neutrophils). On the contrary, cdk5, de-
spite its down-regulation upon miR-199 overexpression, is not a
classical cell cycle-related gene and does not have significant
interactions with other down-regulated genes. To demonstrate
the direct targeting of cdk2 mRNAs by miR-199-5p, we per-
formed dual-luciferase reporter assays. ThemiR-199 significantly
reduced the relative luciferase activity controlled by both the
human and zebrafish cdk2 3′UTRs but did not show the re-
pression of luciferase activity when the predicted binding sites
were mutated (Fig. 3 E and F). These results indicate that miR-
199 suppresses classical cell cycle pathways in neutrophils and
could directly target cdk2 in both zebrafish and humans.
Pharmacological Inhibition of Cdk2 Decreases Neutrophil Motility and
Chemotaxis. CDK2 is expressed and active in human neutrophils
(29), but its function in neutrophils was previously unknown as
CDK2 is traditionally thought to be involved in regulating the
G1/S phase in the cell cycle (30), where neutrophils have exited
the cell cycle and are terminally differentiated. To test whether
cdk2 regulates neutrophil migration, we used NU6140 (31), a
selective CDK2 inhibitor, with at least 10-fold selectivity over
other CDKs. At a concentration of 100 μM, NU6140 did not
affect zebrafish survival or neutrophil numbers (SI Appendix, Fig.
S3). As a control for inhibiting cell cycle progression and DNA
replication, we used a mixture of aphidicolin and hydroxyurea, as
previously reported (32, 33), to uncouple the role of Cdk2 from
DNA replication. Neutrophil recruitment to the infected ear
(Fig. 4 A and B) or tailfin amputation sites (Fig. 4 C and D),
as well as neutrophil motility (Fig. 4 G–I and Movie S2), was
significantly reduced specifically by the Cdk2 inhibition, re-
capitulating the phenotypes caused by miR-199 overexpression.
As a control, Cdk2 inhibition did not affect total neutrophil
numbers in the fish (Fig. 4 E and F). To increase our confidence
in the results obtained with pharmacological Cdk2 inhibition,
2 additional Cdk2 inhibitors (34) were used. A CDK2-selective
inhibitor, CTV313, and a pan-CDK inhibitor, roscovitine, also
blocked neutrophil motility and recruitment in inflammation
models (SI Appendix, Fig. S4 and Movie S2). A previous report
showed that high doses and prolonged treatment with roscovitine
could lead to neutrophil apoptosis (29). To rule out the possi-
bility that the reduced migration observed was due to cell apo-
ptosis, we washed out the reversible inhibitors CTV313 and
roscovitine after neutrophil motility was reduced. Neutrophil
motility recovered after the removal of the inhibitors (SI Ap-
pendix, Fig. S5 and Movie S3), indicating that CDK2 inhibitor
treatments do not result in terminal apoptosis. We then tested
whether the neutrophils under investigation had indeed exited
the cell cycle. No cell division was observed during wounding or
infection (SI Appendix, Fig. S6 A and B and Movie S4), sug-
gesting that neutrophil division is a rare event. Additionally, less
than 3% of the neutrophils in adult kidney marrow were in the S
or G2 phase of the cell cycle (SI Appendix, Fig. S6 C–E). Because
cdk2 has not been previously implicated in regulating neutrophil
migration, we thus determined if our findings could apply to
humans. Primary human neutrophils were isolated and treated
with NU6140. Inhibition of CDK2 significantly reduced chemo-
taxis toward interleukin-8, with a decreased velocity and che-
motaxis index (Fig. 4 J–L and Movie S5). In summary, we report
a previously unknown role for CDK2 in regulating neutrophil
chemotaxis in a way that is separable from its function in DNA
replication.
Fig. 3. miR-199-3 overexpression suppresses the expression of cdk2 in neutrophils. (A) Volcano blot of DEGs with significant expression changes in miR-199–
expressing neutrophils. Down-regulated DEGs are shown in cyan, and up-regulated DEGs are shown in magenta. (B) Pathway analysis of genes down-
regulated by miR-199 in neutrophils. (C) Quantification of the transcript levels of down-regulated genes in neutrophils sorted from the vector or miR-
199-3 zebrafish line (at least 100 embryos per group per repeat). Results from 3 independent experiments are normalized to rpl32 and presented as mean ± SD,
using the Holm–Sidak test. (D) Alignment of mature human and zebrafishmiR-199-5p sequences. (E) Alignment ofmiR-199-5p and predictedmiR-199 binding
sites in human and zebrafish CDK2 3′UTRs. (F) Suppression of Renilla luciferase expression via binding to both zebrafish and human CDK2 3′UTRs by miR-199.
Results of Renilla luciferase activity normalized with firefly luciferase activity from 3 independent experiments and presented as mean ± SD, using the Kruskal–
Wallis test. mut, mutation.
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Catalytic Activity of Cdk2 Is Required for Neutrophil Motility. To
further test our hypothesis that the kinase activity of Cdk2 is
essential for neutrophil motility, we cloned the zebrafish cdk2
gene and tagged it with mCherry at the N terminus using a self-
cleavable 2a peptide (Fig. 5A). Mutations at D145, a residue that
chelates Mg2+ and facilitates adenosine 5′-triphosphate (ATP)
binding to the catalytic cleft, would result in a catalytically dead
and dominant-negative form of CDK2 (35). We constructed a
zebrafish line overexpressing Cdk2 (D145N) in neutrophils,
Tg(lyzC:mcherry-2a-cdk2-d145n)pu19, together with a control line,
Tg(lyzC:mcherry-2a-cdk2)pu20, henceforth referred to as the Cdk2
D145N or wild-type (WT) line, respectively. Again, we observed
a significant reduction of neutrophil motility (Fig. 5 B–D and
Movie S6) and recruitment to the tail amputation site (Fig. 5 E
and F) in the D145N line. To characterize neutrophil chemotaxis
to a single chemoattractant, we bathed embryos in leukotriene
B4 and quantified neutrophil emigration from the caudal he-
matopoietic tissue (CHT) to the caudal fin. The percentage of
neutrophils migrating outside the CHT and the distance neu-
trophils traveled in the caudal fin were significantly reduced in
the D145N line (Fig. 5 G and H, SI Appendix, Fig. S7 A and B,
and Movie S7). In addition, neutrophil motility in the CHT was
reduced (SI Appendix, Fig. S7 C and D and Movie S8). To vi-
sualize neutrophil polarization, the Cdk2 D145N or WT line was
crossed with Tg(mpx:GFP-UtrCH), which labels stable actin in
the trailing edge of migrating neutrophils (36). In Cdk2 D145N-
expressing neutrophils, stable actin is enriched in transient cell
protrusions that quickly retract, displaying disrupted cell polarity
and actin dynamics (Fig. 5I and Movie S9). Hence, our results
indicate that the catalytic activity of Cdk2 is required for neu-
trophil polarization and efficient chemotaxis.
To test whether cdk2 is the primary target of miR-199 that
regulates cell migration, we restored Cdk2 expression in themiR-
199–overexpressing zebrafish neutrophils. Cdk2 expression alone
could partially rescue the migration defects of the neutrophils
carrying miR-199, but not to the vector control level (SI Ap-
pendix, Fig. S8 and Movie S10), suggesting that other miR-199
targets possibly also regulate neutrophil migration. To further
confirm the specific requirement of CDK2 activity in neutrophil
migration, we incubated dHL-60 cells with increasing doses of
inhibitors of CDK1, CDK1/5, CDK2, or CDK4/6. Indeed, only
the CDK2 inhibitor reduced transwell migration in a dose-
dependent manner (SI Appendix, Fig. S9). In addition, transient
expression of dominant-negative Cdk2, but not dominant-negative
Cdk5, reduced neutrophil migration in zebrafish (SI Appendix,
Fig. S10 and Movie S11). Along the same line, knocking down
CDK5 in dHL-60 cells did not affect transwell migration (SI
Appendix, Fig. S11 C–H). These results suggest a specific re-
quirement of CDK2 in regulating neutrophil migration.
CDK2 Regulates Polarization and Signaling in dHL-60 Cells. To gain
more insight into how CDK2 regulates neutrophil migration, 2
CDK2 knockdown dHL-60 cell lines were generated using
2 different short hairpin RNAs. The CDK2 protein levels in
these 2 lines were significantly reduced, whereas the level of
CDK1 or CDK5 remained relatively constant (SI Appendix, Fig.
S11 A and B). Cells deficient in CDK2 were viable with com-
parable surface levels of CD11b, indicating that CDK2 knock-
down did not affect cell differentiation (SI Appendix, Fig. S11 E–G).
CDK2 knockdown cells exhibited hindered transwell migra-
tion toward fMLP (SI Appendix, Fig. S11H) and could not
establish prominent actin-rich lamellipodia when stimulated
with a uniform field of fMLP (SI Appendix, Fig. S12 A and B).
Phospho (p)-myosin light chain 2, which labels the rear of the
cell and drives tail retraction (37), was also mislocalized (SI
Appendix, Fig. S12 A and C). After fMLP stimulation, the acti-
vation of Rac (indicated by the level of p-PAK [P21 (RAC1)
activated kinase]) or the level of phosphatidylinositol (3–5)-
trisphosphate (indicated by the level of p-AKT) (38) was also
reduced in the CDK2 knockdown cells, whereas the p–extracellular
Fig. 4. Inhibition of CDK2 reduces neutrophil motility and chemotaxis in zebrafish and humans. Representative images (A) and quantification (B) of neutrophils
recruited to the infected ear in zebrafish larvae treated with CDK2 inhibitor (NU6140) or the DNA replication inhibitor aphidicolin + hydroxyurea (ApH) are shown.
(Scale bar, 100 μm.) Representative images (C) and quantification (D) of neutrophils recruited to tailfin transection sites in zebrafish larvae treated with NU6140 or
ApH are shown. (Scale bar, 200 μm.) Representative images (E) and quantification (F) of total neutrophil number in zebrafish larvae treatedwith NU6140 or ApH are
shown. (Scale bar, 500 μm.) In A–F, assays were done with 3 individual founders with 3 biological repeats, each containing 20 (for motility) or 25 (for neutrophil
recruitment) fish per group. The result from one representative experiment is shown as mean ± SD, using the Mann–Whitney test. Representative images (G),
velocity (H), and meandering index (I) of neutrophil motility in zebrafish larvae treated with NU6140 or ApH are shown. (Scale bar, 100 μm.) Three embryos each
from 3 different founders were imaged, and quantification of neutrophils in one representative video is shown, using the Kruskal–Wallis test. Representative tracks
(J), mean velocity (K), and chemotaxis index (L) of primary human neutrophils treated with DMSO or NU6140 (50 μM) migrating toward interleukin-8 are shown.
(Scale bar, 100 μm.) Results representative of 3 separate trials are shown. The result is presented as mean ± SEM, using a 2-way paired Welch’s t test.
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signal-regulated kinase level (39) was not affected (SI Appendix, Fig.
S12 D and E), indicating a specific requirement for CDK2 in acti-
vating the phosphatidylinositol 3-kinase (PI3K)/RAC axis. In ad-
dition, unlike CDK4 (40), CDK2 does not regulate neutrophil
extracellular trap (NET) formation (SI Appendix, Fig. S13), re-
iterating that different CDKs have unique functions in
neutrophils.
miR-199 Overexpression or Cdk2 Inhibition Ameliorates Systemic
Inflammation. With the findings that miR-199 overexpression or
Cdk2 abrogation hinders neutrophil chemotaxis, we sought to
determine whether these manipulations could alleviate acute
systemic inflammation caused by a lethal dose of Pseudomonas
aeruginosa (PAK) in the circulation (41). Survival of the zebra-
fish embryos was significantly improved in the miR-199 line and
the Cdk2 D145N line compared with their respective controls
(Fig. 6 A and B). Consistently, NU6140 treatment improved the
infection outcome, whereas DNA replication inhibitors were
detrimental to the infected host (Fig. 6C). Roscovitine, the pan-
CDK inhibitor (42) currently in phase II trial, also displayed a
protective effect at 15 μM but was detrimental at 30 μM, possibly
due to the inhibitory effect on cell proliferation and tissue repair
as previously reported in cell culture and ex vivo bone marrow
isolations (43) (Fig. 6D). To further assess the protective role of
miR-199 overexpression or Cdk2 inhibition in another model, we
utilized a previously described sterile inflammation model of
endotoxemia (44). Neutrophil-specific miR-199 overexpression
or roscovitine treatment again reduced host mortality (Fig. 6 E
and F). These results indicate that miR-199 overexpression or
Cdk2 inhibition can have a protective effect during acute systemic
inflammation and infection, without generating an immune sup-
pression status with defects in pathogen clearance.
Discussion
miRNAs play a pivotal role in diseases driven by neutrophilic
inflammation (45–47), where both protective and detrimental
effects are observed. Currently, there is no systemic screen to
identify miRNAs that regulate neutrophil migration, possibly
because neutrophils are terminally differentiated and not ge-
netically tractable in cell culture. In the present study, we per-
formed an in vivo functional screen in zebrafish and identified
miR-199 as a critical regulator of neutrophil migration and che-
motaxis. miR-199 hinders neutrophil motility by downregulating
genes in the canonical cell cycle pathways, and directly targets cdk2.
We further demonstrate that the catalytic activity of Cdk2 is critical
for neutrophil migration and chemotaxis, whereas DNA replication
and an active cell cycle are not essential (SI Appendix, Fig. S7E).
Although no prior studies have investigated the role of miR-
199 in neutrophils, its role in suppressing inflammation and cell
migration has been reported in cancer cells. In ovarian cancer
cells, MIR-199 inhibits canonical NF-κB signaling by targeting
Fig. 5. Dominant-negative Cdk2 suppresses neutrophil motility and che-
motaxis. (A) Schematic of the construct for neutrophil-specific expression of
Cdk2 WT or D145N. Representative images (B), velocity (C), and meandering
index (D) of neutrophil motility in Cdk2 WT or D145N zebrafish line are
shown. (Scale bar, 100 μm.) Three embryos each from 3 different founders
were imaged, and quantification of neutrophils in one representative video
is shown, using the Kruskal–Wallis test. Representative images (E) and
quantification (F) of neutrophil recruitment to the tailfin transection sites in
Cdk2 WT or D145N zebrafish line are shown. (Scale bar, 200 μm.) Repre-
sentative images (G) and quantification (H) of neutrophils migrated to the
caudal fin (blue box) normalized to total neutrophils in the trunk (red box) in
Cdk2 WT or D145N zebrafish line are shown. (Scale bar, 200 μm.) (I) Simul-
taneous imaging of the calponin-homology domain of utrophin (Utr-CH)-
GFP distribution in neutrophils expressing either WT or D145N Cdk2. Data
are representative of more than 3 separate time-lapse videos. (Scale bar,
50 μm.) In E–H, the assays were done with 3 individual founders with 3 bi-
ological repeats, each containing 20 (for motility) or 25 (for neutrophil re-
cruitment) fish per group. The result is presented as mean ± SD, using the
Mann–Whitney test.
Fig. 6. Cdk2 inhibition and miR-199 overexpression improve zebrafish sur-
vival during systemic bacterial infection or sterile inflammation. (A) Survival
of zebrafish larvae after infection of 1,000 CFU of PAK administered in-
travenously (i.v.) in the vector or miR-199 zebrafish line. Vector lines were
left uninfected or injected with PBS as a control. (B) Survival of zebrafish
larvae after infection of 1,000 CFU of PAK administered i.v. in the Cdk2 WT
or D145N zebrafish line. (C) Survival of zebrafish larvae treated with vehicle,
NU6140 (100 μM), or ApH (150 μM/20 mM) or left untreated after infection
with 1,000 CFU of PAK administered i.v. (D) Survival of zebrafish larvae
treated with indicated dilutions of roscovitine infected with 1,000 CFU of
PAK administered i.v. (E) Survival of zebrafish larvae after injection of 25 ng
of LPS administered i.v. in the vector or miR-199 zebrafish line. (F) Survival
of zebrafish larvae treated with indicated dilutions of roscovitine injected
with 25 ng of LPS i.v. In A–F, 1 representative experiment of 3 independent
experiments (n ≥ 20 each group) is shown, using the Gehan–Breslow–
Wilcoxon test.
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IKBKB, thus preventing the production of proinflammatory cy-
tokines (28). In our current work, the miR-199/ikbkb axis was
also validated in neutrophils, further supporting the evolutionary
conservation of miRNA–target interaction in vertebrates. Sup-
pression of ikbkb may also contribute to the survival of zebrafish
during systemic inflammatory challenge due to its central role in
inflammation. From the perspective of cell migration and re-
cruitment, miR-199 hinders cancer cell migration and invasion by
downregulating β1 integrin levels (48), decreasing CD44 ex-
pression and hence interaction with Ezrin (49), or by directly
targeting α3 integrin (50) in various cancer cells. Introduction
of miR-199 alleviated invasiveness in vitro through targeting
the Wnt or HIF-1α/VEGF pathway (51, 52). Here, we provide
evidence that miR-199 is a suppressor of cell migration in
leukocytes, expanding its role beyond cancer biology. The
MIR-199a-5p levels were increased in the plasma of patients
with neutrophilic asthma (53) and inflammatory bowel disease
(54), suggesting that MIR-199 possibly plays physiological
functions in inflammation. In addition, MIR-199b suppresses
myeloid differentiation (55), which can also contribute to its
role in suppressing the innate immunity.
The most surprising finding of our study is that miR-199 pre-
dominantly regulates the cell cycle-dependent kinase cdk2 in
terminally differentiated neutrophils. A significant inverse re-
lationship of MIR-199 and CDK2 was observed in samples of
patients with breast cancer or head and neck cancer, indicating
that MIR-199 possibly regulates CDK2 in human pathologi-
cal conditions (SI Appendix, Fig. S14). CDK2 is a cell cycle-
dependent kinase whose cofactors, cyclin E and cyclin A, are
expressed during mitosis, activating its kinase activity and cell
cycle progression (30). CDK2 phosphorylates transcriptional
factors to drive cell cycle progression and cell differentiation,
and to alter cell metabolism and DNA double-strand break re-
pair (reviewed in ref. 56). Although the literature of CDK2 in the
context of innate immunity and inflammation is scarce (as
reviewed in ref. 57), CDK2 possibly regulates the secretion of
inflammatory cytokines in macrophages. In addition, a single-
nucleotide polymorphism of CDK2 is significantly enriched
in asthma patients (58), supporting the possible function of
CDK2 in regulating inflammation.
Here, we provide evidence that the kinase activity of CDK2 is
required for neutrophil migration. Although the cytosolic CDK
inhibitors have been implicated in regulating cell migration (59),
there are no previous reports showing that CDK2 directly reg-
ulates cell migration. However, there is a limitation in our work
that the substrates directly phosphorylated by CDK2 in neutro-
phils are not yet identified. CDK2 is a serine/threonine protein
kinase, which uses the KLAD*FGLA kinase consensus domain
to phosphorylate the “Ser/Thr-Pro-X-H/K/R” motif of target
proteins, with additional prevalent noncanonical target motifs
(60). Over 100 proteins are likely phosphorylated by CDK2-
cyclinA in human embryonic kidney (HEK) cells (61), and the
CDK2-cyclinE substrates are not well characterized. Extensive
work will be required to characterize how CDK2 contributes
to the signaling network required for neutrophil chemotaxis.
CDK2 is possibly present in the neutrophil cytosol, and its ex-
pression is up-regulated upon lipopolysaccharide (LPS) stimu-
lation (62), supporting the possibility that CDK2 ties in the
signaling pathways downstream of the chemokine receptors. As a
step closer to the potential mechanism, we have observed de-
fective cell polarization in both zebrafish neutrophils and dHL-60
cells upon CDK2 abrogation. In addition, a specific defect in
activating the PI3K/RAC2 axis is observed in CDK2-deficient
dHL-60 cells, providing a direction for our future research.
Acute neutrophilic overinflammation is a pressing concern in
many disease pathologies (1), and methods that simultaneously
hinder neutrophil migration and inflammation while preserving
immune integrity are highly desired. Our study presents an acute
method to dampen neutrophil recruitment by inhibiting Cdk2,
which reduces the lethality caused by acute systemic inflammation.
Although reduced migration alone can contribute to reduced in-
flammation, alterations in other neutrophil functions, such as
NETosis, phagocytosis, oxidative burst, degranulation, and cyto-
kine release, may also contribute to increased survival. Previous
studies have demonstrated roles for CDK4/6 in the formation of
neutrophil extracellular traps (40), CDK7/9 in neutrophil apo-
ptosis (62), and CDK5 in the secretion of neutrophil-specific
granules (63). It remains to be determined whether other neu-
trophil functions in addition to migration are regulated by CDK2.
The pan-CDK inhibitor roscovitine competes with ATP for the
occupation of the kinase active site (64) and is currently in mul-
tiple phase II clinical trials to inhibit cystic fibrosis and multiple
types of tumors (https://clinicaltrials.gov). Previous studies in mice
have shown that treatment with roscovitine at 10 to 100 mg/kg for
3 to 7 d after inflammation induction resulted in decreased
neutrophil infiltration into the inflamed tissue and better clin-
ical outcome (29). This reduced neutrophil recruitment was
attributed to CDK9 inhibition and neutrophil apoptosis (65),
whereas a link to CDK2 was not shown. Our data add to the list
of non–cell cycle-related functions of CDKs, where acute in-
hibition of CDK2 suppresses neutrophil migration without af-
fecting their viability. In Cdk2 knockout mice, normal myeloid
cell numbers during resting and stressed conditions were ob-
served (66), and no developmental defects other than a smaller
body size and sterility were noted (67). Thus, CDK2 inhibition
is not expected to cause adverse side effects, and thus presents
an attractive strategy for short-term and long-term control of
inflammation, which may be better tolerated than a pan-CDK in-
hibitor, such as roscovitine. In summary, our study demonstrates
previously unappreciated roles of miR-199 and CDK2 in regulating
neutrophil migration and points to new directions in managing
neutrophilic inflammation.
Materials and Methods
miRNA Sequencing. Neutrophil and apical epithelial cells were sorted from
transgenic zebrafish lines Tg(lyzC:GFP) and Tg(Krt4:GFP) at 3 d post-
fertilization (dpf) using fluorescence-activated cell sorting (FACS). Total RNA
was exacted using an Ambion mirVana kit (without enrichment for small
RNA). A library was prepared using a TruSeq Small RNA Preparation Kit
(Illumina). DNA of 145 to 160 bp was excised from Invitrogen 6% Novex TBE
Gel and sequenced using an Illumina HiSeq 2000 system with paired-end
reads of 50 bp with a total of 2 to 3 million per sample. The miRNA se-
quencing was performed at the University of Wisconsin Collaborative Ge-
nomics Core. For analysis, sequencing reads were mapped to the zebrafish
genome (GRCz11) using an RNAseq aligner from STAR (v2.5) (68), using
previously described parameters (69) to evaluate expression levels of
zebrafish mature miRNAs based on uniquely mapped reads with the pa-
rameters “-s 1 –Q 10.” Before trimmed mean of M values (TMM) normali-
zation and differential expression (DE) analysis by edgeR (v3.20.8) (70),
miRNAs whose count per million (cpm) was less than 10 were removed from
all samples. Differentially expressed miRNAs were selected if their false
discovery rate (FDR)-adjusted P values were less than 0.05.
RNASeq. Kidneymarrowwas dissected from 2 adults from Tg(lyzC: miR-199-3-
dendra2)pu19 or Tg(lyzC: vector-dendra2)pu7, and neutrophils were sorted
using FACS. Total RNA was extracted using a RNeasy Plus Mini Kit (no. 74104;
Qiagen). RNAseq was performed at the Center for Medical Genomics at
Indiana University School of Medicine. Samples were polyA-enriched and
sequenced with an Illumina HiSeq 4000 ultralow system with reads ranging
from 37 to 44 million. The RNAseq aligner from STAR (v2.5) (71) was
employed to map RNAseq reads to the reference genome, zebrafish (GRCz11),
with the following parameter: “–outSAMmapqUnique 60.” Uniquely mapped
sequencing reads were assigned to genes using featureCounts (from subread
v1.5.1) (71) with the following parameter: “-p -Q 10.” The genes were filtered
for further analysis if their read was less than 0.5 cpm in more than 3 samples.
The TMM method was adopted for gene expression normalization across all
samples, followed by DE analysis between different conditions using edgeR
(v3.20.8). Differentially expressed genes (DEGs) were determined for the com-
parison if its FDR-adjusted P value was less than 0.05 and the amplitude of fold
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change (FC) was larger than linear 2-fold. The functional analysis was per-
formed on DEGs of our interest with a cutoff of FDR < 0.05 to identify sig-
nificantly overrepresented gene ontology and/or Kyoto Encyclopedia of Genes
and Genomes pathways, using the Database for Annotation, Visualization, and
Integrated Discovery (72).
Protein–Protein Interactions. Genes/proteins interacting with cdk2 or cdk5 in
Danio rerio were retrieved from the protein–protein interactions database,
STRING v11 (https://string-db.org/) (73). The pairs were filtered if their con-
fidence scores were less than 0.4. The significance value of enrichment was
calculated based on the hypergeometric model.
qRT-PCR. MicroRNAs were extracted using a mirVana miRNA purification kit
(Thermo Fisher Scientific) and reverse-transcribed with a Universal cDNA
Synthesis Kit II (Exiqon). qRT-PCR was performed with ExiLENT SYBR Green
Master Mix (Exiqon) using predesigned primers (Exiqon) in a LightCycler 96
Real-Time PCR System (Roche Life Science). U6 was used as a loading control.
Messenger RNAs were extracted using the RNeasy Plus Mini Kit (no. 74104;
Qiagen). One-step RT-qPCR was performed using a SuperScript III Platinum
SYBR Green kit (Invitrogen) in a LightCycler 96 Real-Time PCR System with
the loading control rpl32. The relative levels of microRNAs and mRNA were
calculated using the deltaCt method. The specificity of the primers was
verified as a single peak in the melt-curves. The relative fold change
with correction of the primer efficiencies was calculated following in-
structions provided by Real-time PCR Miner (http://ewindup.info/miner/
data_submit.htm) (74). The following primers were used: dre-cdk1+: 5′-
ttggggtcccagtaagagtcta-3′, dre-cdk1−: 5′-ggtgtggaatagcgtgaagc-3′, dre-cdk2+:
5′-agatggcagagaccttctcg-3′, dre-cdk2−: 5′-cggaaaaaccgatgaacaag-3′, dre-cdk5+:
5′-tgggaacgccaacagaag-3′, dre-cdk5−: 5′-agctggatacatcgggtacg-3′, dre-cdca8+:
5′-atggcaccgctgaagtctac-3′, dre-cdca8−: 5′-cgttgaaggagctttctttga-3′; dre-kif14+:
5′-aggaggctcgcttgaagg-3′; dre-kif14−: 5′-ctctttagccacctgaatgc-3′, dre-mcm5+: 5′-
aagctattgcctgcctgct-3′, dre-mcm5−: 5′-ccctcttcgtgtcagaccat-3′, dre-casp3b+: 5′-
caggatattacgcatggagga-3′, dre-casp3b−: 5′-tcgcacagcgaggagataa-3′, dre-ikbkb+,
5′-gaggagcgagaaacaactgc-3′, dre-ikbkb−: 5′-tggactgcgaactttactgc-3′, dre-rpl32+:
5′-tcagtctgaccgctatgtcaa-3′, and dre-rpl32−: 5′-tgcgcactctgttgtcaatac-3′.
Generation of Transgenic Zebrafish Lines. Genomic DNA fragments (300 to
600 bp) flanking the respective miRNAs were PCR-amplified from zebrafish
genomic DNA using specific primers and inserted into the BbsI site in the
vector backbone as described (22). Briefly, the miRNA, along with the
flanking sequences, was inserted into an intron cassette in a Tol2 backbone
containing the lyzC promoter and SV40 polyA for neutrophil-specific ex-
pression. The zebrafish cdk2 gene was cloned from zebrafish mRNA using
a SuperScript III RT kit (no. 18080044; Invitrogen), amplified with primers
(zCdk2+: 5′-gaaaaccccggtcctatggagtcttttcagaaagtggag-3′ and zCdk2−: 5′-
catggctgattatgattataggcgtaaaggaggcactgg-3′), and inserted into a Tol2-
mcherry-2A backbone. Point mutation was generated using infusion (no.
638920; Takara) site-directed mutagenesis with zCdk2 DN+: 5′-actggc-
taactttggtttggccagagcgttc-3′ and zCdk2 DN−: 5′-ccaaagttagccagtttgatctcgccctg-
3′. Microinjections of fish embryos were performed by injecting 1 nL of mixture
containing 25 ng/μL plasmid and 35 ng/μL Tol2 transposase mRNA in an isotonic
solution into the cytoplasm of embryos at the 1-cell stage. The stable lines were
generated as previously described (36). At least 2 founders (F0) for each line
were obtained. Experiments were performed using F2 larvae produced by
F1 fish derived frommultiple founders to minimize the artifacts associated with
random insertion sites.
Dual-Luciferase Reporter Assay. Both zebrafish and human CDK2 3′UTRs were
amplified from zebrafish or HL-60 cell genomic DNA with a SuperScript III RT
kit (no. 18080044; Invitrogen) and cloned into psiCHECK2 (Promega) at XhoI
and NotI sites with the following primers: zCDK2+:5′-taggcgatcgctcga-
gaacgagatcaactttggcaag-3′, zCdk2−: 5′-ttgcggccagcggccgctgtaacaacataaa
ccaaatgtt-3, hCDK2+: 5′-taggcgatcgctcgagagccttcttgaagccccca-3′, and hCdk2−:
5′-ttgcggccagcggccgctataaaactaggcacatttttttaa-3′. Mutated 3′UTR constructs
were generated using an In-Fusion HD Cloning Kit (Clontech) with the fol-
lowing primers: zCdk2 mut+: 5′-cctgtgtgacccaaaaaaacagctgtgctaatagt-3′,
zCdk2 mut−: 5′-tttgggtcacacaggttgcaatggataatcttca-3′, and hCdk2 mut+: 5′-
aaaacgtgaccgaggagtctattttaaagaattcgg-3′. DNA encoding miR-199 or vector
was amplified from the construct used for expression in zebrafish and
inserted into pcDNA3.1 at the HindIII/XbaI cloning sites using the following
primers: pcDNA-199+: 5′-gtttaaacttaagcttgccaccatggatgaggaaatcgc-3′ and
pcDNA-199−: 5′-aaacgggccctctagagaccggtacccccgggctgc-3′.
Live Imaging. Larvae at 3 dpf were settled on a glass-bottom dish, and im-
aging was performed at 28 °C. Time-lapse fluorescence images in the head
mesenchyme were acquired with a laser-scanning confocal microscope
(LSM710; Zeiss) with a Plan-Apochromat 20×/0.8 M27 objective. Neutrophil
motility at the CHT was imaged using a Zeiss EC Plan-NEOFLUAR 10×/0.3
objective. For neutrophil nucleus and cytosol reporter line imaging, an LD
C-Apochromat 40×/1.1 W Korr M27 objective was used. The green and red
channels were acquired sequentially with 0.1 ∼ 0.3% power of the 488-nm
laser and 0.5 ∼ 2% power of the 561-nm laser, respectively, with a 200-μm
pinhole at a speed of 1.27 μs per pixel and averaged (line 2). The fluo-
rescent stacks were flattened using the maximum intensity projection and
overlaid with a single slice of the bright-field image. Neutrophil chemotaxis
upon LTB4 treatment was captured with a Zeiss ZV16 dissection microscope
at a magnification of 2× every 15 s for 30 min.
Inflammation Assays in Zebrafish. Zebrafish wounding and infection were
performed as described (22). Briefly, 3-dpf larvae were amputated posterior
to the notochord or inoculated with PAK into the left otic vesicle or into the
vasculature at 1,000 colony-forming units (CFU) per embryo. The larvae were
fixed in 4% paraformaldehyde at 1 h postwounding or postinfection. Neu-
trophils were stained with Sudan Black, and the numbers at the indicated
regions were quantified. For LTB4 recruitment assays, 3-dpf zebrafish larvae
were treated with 30 nM LTB4 for 15 min and fixed. Neutrophils were
stained with Sudan Black, and the numbers at the indicated regions
were quantified.
Generation of Stable HL-60 Cell Lines. HL-60 cells were obtained from the
American Type Culture Collection (CCL-240) and cultured using Roswell Park
Memorial Institute (RPMI)-1640 with 4-(2-hydroxyethyl)-1-piperazineethanesulfonic
acid (Hepes) supplemented with 10% fetal bovine serum (FBS) and sodium bicar-
bonate. The lentiviral backbone pLIX_403 was a gift from David Root, Broad In-
stitute, Cambridge,MA (plasmid no. 41395; Addgene). The DNA sequence flanking
MIR-199 was cloned from HL-60 cell genomic DNA and then cloned into a back-
bone containing dendra2. ThemiRNA and dendra2 reporter were then cloned into
pLIX_403 vector using the NheI/AgeI sites with the following primer set: pLIX-mir+:
5′-tggagaattggctagcgccaccatggatgaggaaatcgc-3′ and pLIX-mir−: 5′-cata-
cggataaccggttaccacacctggctgggc-3′. Stable HL-60 cell lines were gener-
ated as described (25, 75). Briefly, HEK-293 cells were transfected with
pLIX_403 or pLKO.1, together with VSV-G and CMV8.2 using Lipofectamine
3000 (Thermo Fisher Scientific). The viral supernatant was harvested on day
3 and concentrated with Lenti-X concentrator (no. 631232; Clontech). HL-
60 cells were infected with concentrated lentivirus in complete RPMI me-
dium supplemented with 4 μg/mL polybrene (TR-1003-G; Sigma) at 2,500 × g
for 1.5 h at 32 °C and then selected with 1 μg/mL puromycin (A1113803;
Gibco) to generate stable lines.
Inhibitor Treatment for Zebrafish Larvae. CDK2 inhibitors NU6140 (no. ALX-
270-441; Enzo), CTV313 (no. 238803; Sigma), and roscovitine (no. S1153;
Selleckchem) were dissolved in dimethyl sulfoxide (DMSO) to make a 100 mM
stock and then further diluted in E3 to working concentrations (100 μM for
recruitment and motility assays and indicated concentration for survival
assays). For inhibiting DNA replication, 150 μM aphidicolin and 20 mM hy-
droxyurea (no. A0781; Sigma) in 1% DMSO were used as previously de-
scribed (32). For neutrophil recruitment and random motility assays, larvae
were pretreated with the inhibitor for 1 h before experimental procedures.
For survival assays, larvae were pretreated and kept in the inhibitors from
1 h postinfection.
Transwell Migration Assay. The dHL-60 transwell assays were performed as
described (75). Briefly, 2 × 106 differentiated cells per milliliter were resus-
pended in Hanks’ balanced salt solution (HBSS) with 0.5% FBS and 20 mM
Hepes. One hundred microliters was placed into a 6.5-mm-diameter, 3-μm
pore size transwell inset (no. 3415; Corning) and allowed to migrate for 2 h
at 37 °C toward 100 nM fMLP in 500 μL of HBSS in a 24-well plate. Loading
controls were done by directly adding 100 μL of cells to 400 μL of HBSS. Cells
that migrated to the lower chamber were released with 0.5 M ethyl-
enediaminetetraacetic acid and counted using a BD LSRFortessa flow
cytometer with an acquisition time of 30 s. The counts were normalized
with the total numbers of cells added to each well, and the data were then
gated for live cells and analyzed with Beckman Kaluza 2.1 software.
Primary Neutrophil Isolation and Chemotaxis Assay. Primary human neutro-
phils were isolated with a Miltenyi MACSxpress Neutrophil Isolation Kit. Cells
were stained for 10 min with calcein AM and washed with phosphate-
buffered saline (PBS). A total of 107 cells per milliliter were incubated in
RPMI + 0.1% human serum albumin (HSA) containing 50 μM NU6104 or
DMSO at 37 °C/5% CO2 for 45 min. Microfluidic devices were fabricated as
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previously described (76). Microfluidic chambers were coated with 10 μg/mL
fibrinogen for 1 h at 37 °C in PBS. Three microliters of neutrophil suspension
(4 × 106 cells per milliliter) was added to the device, and 5 μm of interleukin-
8 was added to the source port. The gradient was allowed to set up and
equilibrate in a 37 °C humidified chamber for 15 min before imaging. Time-
lapse imaging was performed using a 10× numerical aperture (NA) of 0.45,
or 60× NA of 1.4 objective and motorized stage (Ludl Electronic Products) on
an inverted microscope (Eclipse TE300), using a charge-coupled device camera
(CoolSNAP ES2), and captured into MetaVue imaging software v6.2. Images
were taken every 30 s for 30 to 45 min, with up to 8 devices being imaged
simultaneously. Tracking and velocity quantification were performed as
described (9).
Survival Assay. Larvae at 3 dpf were injectedwith 1 nL of 25 ng/nL LPS or 1,000
CFU of PAK into the tail vein and incubated individually in 96-well plates.
Survival was tracked for 4 d or when a group reached 100% mortality.
Representative results of at least 3 independent experiments (n ≥ 20 larvae in
each experiment) were shown.
Statistical Analysis. Statistical analysis was carried out using PRISM 6
(GraphPad). The Mann–Whitney test (when comparing 2 groups), Kruskal–
Wallis test (when comparing with a single group), and Gehan–Breslow–
Wilcoxon test (for survival curve comparison) were used in this study as in-
dicated in the figure legends. Individual P values are indicated in the figures,
with no data points excluded from statistical analysis. One representative
experiment of at least 3 independent repeats is shown. For qPCR, each gene
was normalized to a reference gene and compared with the Holm–Sidak test
(individual comparison with paired value), where each P value and degree of
freedom was adjusted for respective multiple comparisons.
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